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Summary
Background As the COVID-19 pandemic continues to unfold, the infection-fatality risk (ie, risk of death among all 
infected individuals including those with asymptomatic and mild infections) is crucial for gauging the burden of 
death due to COVID-19 in the coming months or years. Here, we estimate the infection-fatality risk of severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City, NY, USA, the first epidemic centre in the USA, 
where the infection-fatality risk remains unclear.
Methods In this model-based analysis, we developed a meta-population network model-inference system to estimate 
the underlying SARS-CoV-2 infection rate in New York City during the 2020 spring pandemic wave using available 
case, mortality, and mobility data. Based on these estimates, we further estimated the infection-fatality risk for all ages 
overall and for five age groups (<25, 25–44, 45–64, 65–74, and ≥75 years) separately, during the period March 1 to 
June 6, 2020 (ie, before the city began a phased reopening).
Findings During the period March 1 to June 6, 2020, 205 639 people had a laboratory-confirmed infection with 
SARS-CoV-2 and 21 447 confirmed and probable COVID-19-related deaths occurred among residents of New York 
City. We estimated an overall infection-fatality risk of 1·39% (95% credible interval 1·04–1·77) in New York City. Our 
estimated infection-fatality risk for the two oldest age groups (65–74 and ≥75 years) was much higher than the 
younger age groups, with a cumulative estimated infection-fatality risk of 0·116% (0·0729–0·148) for those aged 
25–44 years and 0·939% (0·729–1·19) for those aged 45–64 years versus 4·87% (3·37–6·89) for those aged 65–74 years 
and 14·2% (10·2–18·1) for those aged 75 years and older. In particular, weekly infection-fatality risk was estimated to 
be as high as 6·72% (5·52–8·01) for those aged 65–74 years and 19·1% (14·7–21·9) for those aged 75 years and older.
Interpretation Our results are based on more complete ascertainment of COVID-19-related deaths in New York City 
than other places and thus probably reflect the true higher burden of death due to COVID-19 than that previously 
reported elsewhere. Given the high infection-fatality risk of SARS-CoV-2, governments must account for and closely 
monitor the infection rate and population health outcomes and enact prompt public health responses accordingly as 
the COVID-19 pandemic unfolds.
Funding National Institute of Allergy and Infectious Diseases, National Science Foundation Rapid Response Research 
Program, and New York City Department of Health and Mental Hygiene. 
Copyright © 2020 Elsevier Ltd. All rights reserved.
Introduction
Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) emerged in late 2019 in China and has 
subsequently spread to more than 200 other countries. As 
of Oct 5, 2020, over 35 million cases of COVID-19 and 
over 1 million COVID-19-related deaths have been 
reported worldwide.1 As the pandemic continues to 
unfold and populations in many places worldwide largely 
remain susceptible, understanding the severity, and, in 
particular, the infection-fatality risk of the virus is crucial 
for gauging the full impact of COVID-19 in the coming 
months or years. However, estimating the infection-
fatality risk of SARS-CoV-2 is challenging due to the large 
number of undocumented infections, fluctuating 
infection detection rates, and inconsistent reporting of 
fatalities. Furthermore, the infection-fatality risk of 
SARS-CoV-2 could vary by location, given differences in 
demographics, health-care systems, and social structures 
(eg, inter generational households are the norm in some 
societies whereas older adults commonly reside and 
congregate in long-term care and adult care facilities in 
other societies). Most estimates of infection-fatality risk 
for SARS-CoV-2 to date have come from data recorded in 
China, the Diamond Princess cruise ship, and France.2–5 As 
yet, the infection-fatality risk in the USA—the country 
currently reporting the largest number of cases1—
remains unclear.
New York City, NY, USA, reported its first case of 
COVID-19 on March 1, 2020, in a traveller, and quickly 
became the epicentre of the pandemic in the country.6 
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Intense community transmission occurred during 
the following 3 months before a series of public health 
interventions brought the pandemic under control. In 
particular, public schools in the city were closed on 
March 16, 2020, and a citywide stay-at-home order was 
imposed on all non-essential workers starting the week 
of March 22, 2020.7 The city was able to reopen industries 
according to a phased schedule starting the week of 
June 7, 2020. By June 6, 2020, before the city’s phased 
reopening, over 200 000 people had been diagnosed with 
laboratory-confirmed SARS-CoV-2 infection and more 
than 20 000 COVID-19-related deaths had been reported 
in the city. Since the beginning of the pandemic, the New 
York City Department of Health and Mental Hygiene 
(DOHMH) and the Mailman School of Public Health at 
Columbia University (New York City, NY) have been 
collaborating to generate real-time model projections in 
support of the city’s pandemic response. Our model-
inference system uses a meta-population network model 
to simulate SARS-CoV-2 transmission in the city’s 
42 United Hospital Fund neighbourhoods.8 The model is 
run in conjunction with the ensemble adjustment 
Kalman filter9 and fit simultaneously to case and 
mortality data for each of the 42 neighbourhoods 
while accounting for under-detection, delay between 
infection, case reporting, and death, and changing inter-
ventions (eg, physical distancing). In this analysis, we 
applied this network model-inference system to estimate 
the infection-fatality risk for five age groups (ie, <25, 
25–44, 45–64, 65–74, and ≥75 years) and all ages overall, 
from March 1 to June 6, 2020. In the process, we also 
estimated infection detection rates (ie, the fraction of 
infections documented as confirmed cases) and the 
cumulative infection rate by June 6, 2020.
Methods
Study design and data
In this model-based analysis, we aggregated laboratory 
confirmed SARS-CoV-2 infections reported to the New 
York City DOHMH by week of diagnosis and age group 
(<1, 1–4, 5–14, 15–24, 25–44, 45–64, 65–74, and ≥75 years) 
for each of the 42 United Hospital Fund neighbourhoods8 
in New York City, according to the patient’s residential 
address at time of reporting. We aggregated mortality data 
for confirmed and probable COVID-19-associated deaths 
from deaths registered and analysed by the New York City 
DOHMH. Confirmed COVID-19-asso ciated deaths were 
defined as those occurring in people with laboratory-
confirmed SARS-CoV-2 infection; and probable COVID-19 
deaths were defined as those with COVID-19, SARS-CoV-2, 
or a similar term listed on the death certificate as an 
immediate, underlying, or contri buting cause of death but 
did not have laboratory confirmation of SARS-CoV-2 
infection.10 Due to privacy concerns, the New York City 
DOHMH aggregated mortality data to five coarser age 
groups (<18, 18–44, 45–64, 65–74, and ≥75 years) for each 
neighbourhood by week of death. To match with the age 
grouping for case data, we used the citywide fraction of 
deaths occurring in each of the five finer age groups (ie, <1, 
1–4, 5–14, 15–24, 25–44) to apportion deaths in the younger 
than 18 and 18–44 year age categories. For this study, case 
and mortality data were both retrieved on Aug 7, 2020.
Research in context
Evidence before this study
We searched PubMed for studies published from database 
inception to July 1, 2020, with no language restrictions, 
on the fatality risk of COVID-19 using the terms “COVID-19” and 
“fatality”. Our search returned 376 papers, from which we read 
the abstracts and identified 36 relevant studies. Most studies 
estimated the crude case–fatality risk (CFR; ie, number of deaths 
per number of confirmed cases) or adjusted CFR (ie, adjusting the 
crude CFR for delay from infection or diagnosis to death). For all 
ages overall, estimated crude CFR ranged 0–28% (30 estimates) 
and estimated adjusted CFR ranged 0·12–13·1% (24 estimates). 
Several studies also estimated age-specific CFR and reported 
higher CFR among older adults than in younger age groups. 
Four studies reported infection-fatality risk (ie, number of deaths 
among all infections). Of the four studies reporting infection-
fatality risk, three also included age-specific estimates with 
varying age grouping.
Added value of this study
Using a comprehensive epidemic model-inference system and 
detailed population data of weekly cases, deaths, and mobility, 
we estimated the infection-fatality risk of severe acute 
respiratory syndrome coronavirus 2 for all ages overall and by 
age group in New York City, NY, USA, during the 2020 spring 
pandemic (March 1, to June 6, 2020). We also estimated the 
fluctuations in infection-fatality risk over the course of the 
pandemic. Our estimates addressed three main challenges in 
estimating the infection-fatality risk of COVID-19: age 
differences, under-ascertainment of deaths, and under-
detection of infections.
Implications of all the available evidence
We estimated that the overall infection-fatality risk was 
approximately double previous estimates for elsewhere during 
earlier or similar periods. Our results are based on more 
complete ascertainment of COVID-19-associated deaths in 
New York City than are those from previous studies, and thus 
probably reflect the true, higher burden of death due to 
COVID-19 than previously reported elsewhere. Given this high 
infection-fatality risk, governments must account for and 
closely monitor the infection rate and population health 
outcomes and enact prompt public health responses 
accordingly as the COVID-19 pandemic unfolds.
For more on New York City’s 
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We used mobility data to model changes in the 
rate of SARS-CoV-2 transmission due to public health 
interventions implemented during the pandemic. 
We sourced these data from SafeGraph11,12 and they 
contained counts of visitors to locations in each zip code 
based on mobile device locations. The released data were 
anonymised and aggregated in weekly intervals (with 
weeks defined as Sunday to Saturday). We spatially 
aggregated these data to the neighbourhood level.
This study was classified as public health surveillance 
and was exempt from ethical review and informed 
consent by the Institutional Review Boards of both 
Columbia University and New York City DOHMH.
Meta-population network transmission model
Our meta-population network model simulated intra-
neighbourhood and inter-neighbourhood transmission of 
SARS-CoV-2 and assumed susceptible-exposed-infectious-
removed dynamics, per the following equation system: 
where Si is the number of susceptible individuals, Ei is 
the number of exposed (but not yet infectious) 
individuals, Ii is the number of infectious individuals, 
Ri is the number of removed individuals (either rec-
overed or deceased), and Ni is the total population from 
a given age group in neighbourhood i. Due to model 
complexity and a scarcity of information for para-
meterising interactions among age groups, we mo-
delled each age group separately (ie, combining all 
sources of infection to each age group); as such, system 
(1) describes the spatial transmission across neighbour-
hoods with no interactions among age groups. t is time, 
and we make  this time dependence explicit for the 
parameters to indicate that they were estimated for 
each week and could vary over time due to disease 
seasonality or public health interventions, or both; 
state variables (Si, Ei, Ii and Ri) are inherently vary with 
time. βcity(t) is the citywide transmission rate, which 
incorporated seasonal variation as observed for OC43, a 
betacoronavirus in humans from the same genus as 
SARS-CoV-2 (appendix pp 1–3, 11–14). To allow for 
differential transmission in each neigh bourhood, we 
included a multiplicative factor, bi, to scale neighbour-
hood local transmission rates. Z is the latency period 
and D is the infectious period (appendix pp 4–6).
The matrix [cij(t)] represents changes in contact rates 
over time and connectivity among neighbourhoods and 
was calculated on the basis of mobility data. Briefly, 
we calculated changes in contact rates (either intra-
neighbourhood or inter-neighbourhood) for week-t as a 
ratio of the number of visitors during week-t to the 
number of visitors during the week of March 1, 2020 (the 
first week of the pandemic in New York City when no 
interventions were in place), and further scaled by a 
multiplicative factor m1; m1 was estimated along with 
other parameters (appendix pp 4–6). To calculate the 
connectivity among the neighbourhoods, we first divided 
the inter-neighbourhood mobility by the local mobility, 
which gave a relative measure of connectivity (eg, if 
two neighbourhoods are highly connected with lots 
of individuals travelling between them, inter-neigh-
bourhood mobility would be closer to 1, but if they were 
not highly connected then inter-neighbourhood mobility 
would be much lower than 1); we then scaled 
these relative rates by a multiplicative factor m2, which 
was also estimated along with other parameters 
(appendix pp 4–6).
Observational model 
To account for delays in diagnosis and detection, we 
included a lag of time from infectious to detection (ie, an 
infection being diagnosed as a case), drawn from a gamma 
distribution with a mean of Tm and an SD of TSD days. To 
account for under-detection, we included an infection 
detection rate (r)—ie, the fraction of infections (including 
subclinical or asymptomatic infections) reported as cases. 
To calculate the model-simulated number of new cases per 
week, we multiplied the model-simulated number of 
infections per day (including those from the previous 
weeks) by the infection detection rate, and further dis-
tributed these simulated cases in time per the distribution 
of time from infectious to detection. We then aggregated 
the daily lagged, simulated cases to weekly totals for model 
inference. Similarly, to calculate the model-simulated 
deaths per week and account for delays in time to death, we 
multiplied the simulated number of infections by the 
infection-fatality risk and then distributed these simulated 
deaths in time per the distribution of time-from-infectious-
to-death lag, and aggregated these daily numbers to weekly 
totals. For each week, we estimated the infection detection 
rate (r), the mean (Tm) and SD (TSD) of time from infectious 
to detection, and the infection-fatality risk on the basis of 
weekly case and mortality data. The distribution of time 
from diagnosis to death was based on observations of 
15 686 confirmed COVID-19-related deaths in New York 
City as of May 17, 2020, from New York City DOHMH 
(gamma distribution with a mean of 9·36 days [SD 9·76]; 
appendix pp 4–6).
Parameter estimation
To estimate model parameters (βcity, Z, D, m1, m2, Tm, TSD, r, 
infection-fatality risk and bi, for i=1,…,42) and state 
dSi = – Sidt
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variables (Si, Ei, and Ii, for i=1,…,42) for each week, we ran 
the meta-population network model stochastically with a 
daily timestep in conjunction with the ensemble 
adjustment Kalman filter and fit to weekly case and 
mortality data from the week starting March 1, 2020, to 
the week ending June 6, 2020. The ensemble adjustment 
Kalman filter uses an ensemble of model realisations 
(n=500 here), each with initial set of parameters and 
variables randomly drawn from a prior range (appendix 
pp 4–6). After model initialisation, the model ensemble 
was integrated forwards in time for a week to calculate 
the model-simulated number of cases and deaths for that 
week; these prior estimates were then combined with the 
observed cases and deaths for the same week to calculate 
the posterior distribution of each model parameter or 
variable for that week per Bayes’ theorem.9 Notably, the 
ensemble adjustment Kalman filter also models the 
observational errors (eg, due to imperfect sensitivity and 
specificity of SARS-CoV-2 RT-PCR tests for case diagnosis) 
over time by specifying an error structure and using this 
information when calculating the posterior distribution.9 
We did this parameter estimation process separately for 
each of the eight age groups (ie, <1, up to ≥75). To include 
transmission from other age groups, we used measured 
intra-group and inter-group contacts from the POLYMOD 
study13 to calculate the total number of contacts made to 
each age group and adjusted the prior range of the 
transmission rate (βcity) during the first week of the 
pandemic for each age group accordingly. We calculated 
the posterior estimate on the basis of case and mortality 
data for each age group, which included all sources of 
infection. Thus, the estimated transmission rate for each 
age group included all sources of transmission.
To account for stochasticity in model initiation, we ran 
the parameter estimation process independently ten 
times. We combined results for each age group from 
these ten runs (each with 500 realisations). To combine 
estimates of the infection-detection rate and infection-
fatality risk for those younger than 25 years or all ages 
overall, we weighted the age-group specific estimates 
(median and credible interval [CrI]) by the fraction of 
estimated infections from each related age group.
Model validation
As a model validation, we compared our estimates of 
cumulative infection rates to three independent serology 
datasets measuring the seroprevalence of antibodies to 
SARS-CoV-2 during the pandemic wave in New York 
City. Details of the serology data and matching by timing 
of measurement, age group, and location are in the 
appendix (pp 1, 8, 10).
Role of the funding source
The funders of the study had a role in the data collection 
and no role in study design, data analysis, data 
interpretation, or writing of the report. The corresponding 
author had full access to all the data in the study and had 
final responsibility for the decision to submit for 
publication.
Results
Between March 1 and June 6, 2020, 205 639 people had 
been diagnosed with laboratory-confirmed SARS-CoV-2 
infection and 21 447 COVID-19-related deaths had been 
reported in New York City (table). The epidemic timing 
(eg, peak of confirmed cases and mortality) varied 
substantially by age group and neighbourhood (appendix 
p 10). We were able to use our model-inference system to 
recreate the case and mortality time series for each age 
group and all ages overall (figure 1). For most age 
groups, confirmed cases peaked during the week of 
March 29, 2020, and the mortality rate peaked about 
1 week later than the case rate, due to the time-lag from 
severe infection to death.
However, there was substantial under-detection of 
infections, variations by age group, and fluctuations of 
infection-detection rates over time, in part due to 
changing testing criteria.14,15 The estimated infection-
detection rate for all ages overall started at a low level of 
2·2% (95% CrI 0·3–4·5) during the week of March 1, 2020, 
and increased to 17·4% (11·3–26·1) during the week of 
March 15 (figure 2). However, due to shortages in testing 
and personal protective equipment, testing was restricted 
to severely ill patients in early April14 before it became 
more widely available in May.15 Consistently, the estimated 
infection detection rate dropped to approximately 13% in 
early-mid April, then gradually increased to approximately 
19% in early May and stayed at similar levels through the 
week of May 31, 2020 (figure 2). The estimated infection 
detection rate was highest for the two oldest age groups 
and was substantially lower for younger age groups 
(figure 2). During the week of May 31, 2020, before the 
city began its phased reopening, we estimated that 29·8% 
(21·7–42·3) of infections among those aged 65–74 years 
and 36·0% (28·4–47·9) of infections among those aged 









<25 years 16 332 45 8·56% (5·66–17·5) 0·00972% (0·00405–0·0154)
25–44 years 64 753 734 22·6% (16·6–31·2) 0·116% (0·0729–0·148) 
45–64 years 74 798 4732 22·7% (18·0–29·2) 0·939% (0·729–1·19)
65–74 years 25 460 5181 15·0% (11·4–21·6) 4·87% (3·37–6·89)
≥75 years 24 296 10 755 12·8% (9·92–18·6) 14·2% (10·2–18·1)
Overall 205 639 21 447 17·2% (12·9–25·1) 1·39% (1·04–1·77)
Data are n, median cumulative infection rate with 95% CrI in parentheses, and median estimated infection-fatality 
risk with 95% CrI in parentheses. Data are given to three significant figures. Cases and deaths were reported by the 
New York City Department of Health and Mental Hygiene between March 1 and June 6, 2020. Cumulative infection 
rate is for all those infected by June 6, 2020. And infection-fatality risk is averaged over March 22 to June 6, 2020, with 
estimates for March 1–21 excluded because estimates were less accurate for these earliest weeks when zero or few 
deaths were reported. CrI=credible interval. 
Table: Summary estimates of cases of COVID-19 and COVID-19-related deaths in New York City, NY, USA 
for the period March 1 to June 6, 2020, by age group
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C Cases: 25−44 years
E Cases: 45−64 years
G Cases: 65−74 years
I Cases: ≥75 years
K Cases: overall
March 1 March 22 April 12 May 3 May 24


































































































D Mortality: 25−44 years
F Mortality: 45−64 years
H Mortality: 65−74 years
J Mortality: ≥75 years
L Mortality: overall
March 1 March 22 April 12 May 3 May 24





















Figure 1: Model fit for 
confirmed number of cases 
of COVID-19 (A, C, E, G, I, K) 
and model estimate of 
number of COVID-19 related 
deaths (B, D, F, H, J, L), by age 
group and overall
Boxes and whiskers show the 
median, 50% CrI, and 95% Crl. 
Red dots show the observed 
confirmed case rates (A, C, E, 
G, I, K) and observed mortality 
rates (B, D, F, H, J, L). 
CrI=credible interval.
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11·0% (7·2–17·6) of infections among those younger than 
25 years and 16·8% (11·8–23·1) of infections among 
those aged 25–44 years were detected.
After accounting for the infection-detection rate, the 
epidemic peak for new infections occurred 1–2 weeks 
before the peak in confirmed cases, during the week of 
March 22, 2020, for those younger than 65 years and in all 
ages combined (figure 2). This peak was coincident with 
the timing of public health interventions in New York City 
(ie, public schools closing and the citywide stay-at-home 
order was imposed). Tallied over the entire study period, 
the estimated overall cumulative infection rate was 17·2% 
(95% CrI 12·9–25·1) by June 6, 2020 (table). However, 
estimated cumulative infection rates varied substantially 
across age groups and neighbourhoods in the city 
(figure 3). Specifically, the highest cumulative infection 
rates were in people aged 25–44 years and 45–64 years, and 
those aged 65–74 years and 75 years and older had the 
second highest cumulative infection rates, and those 
younger than 25 years had the lowest cumulative infection 
rate (table). Spatially, among the five boroughs in New 
York City, estimated cumulative infection rates were 
highest in neighbourhoods in the Bronx and lowest in 
neighbourhoods in Manhattan (figure 3).
Our model estimates of cumulative infection rates have 
large uncertainties. To assess the accuracy of our model, 
we compared our model estimates with three datasets of 
seroprevalence of antibodies to SARS-CoV-2 measured 
during three phases of the pandemic in New York City 
(ie, the early phase in March,16 the mid-phase in April,17 
and end phase before reopening in early June;18 details on 
the available serological data and matching by timing of 
measurement, age group, and location are in the 
appendix [pp 1, 7–8]). Although we had large uncertainties 
in our estimates, our estimated cumulative infection 
rates were in line with corresponding measures from 
antibody tests for all three phases of the pandemic wave 
(appendix p 10). Consistent with serological data, our 
model-inference system estimated higher infection rates 
among adults aged 25–64 years than in other age groups 
(appendix p 10). Additionally, the spatial variation esti-
mated by our model-inference system was in line with 
reported measures (ie, highest in the Bronx and lowest 
in Manhattan; appendix p 10). This consistency with 
independent serological data provides some independent 
validation of our model estimates.
During the period March 1 to June 6, 2020, the crude 
confirmed case-fatality risk was 8·23% (16 924 confirmed 
COVID-19-related death and 205 639 confirmed SARS-
CoV-2 infections). After accounting for changing infection 
detection rates and excluding the first 3 weeks of the study 
period (ie, March 1–21, 2020, in which none or few deaths 
were reported, hence making the model estimates less 
accurate), we estimated that the overall infection-fatality 
risk, including both confirmed and probable deaths, was 
1·39% (95% CrI 1·04–1·77) during March 22 to June 6, 2020 
(table). If only confirmed COVID-19-related deaths were 


















































































































































































































































































First day of week, 2020
Figure 2: Estimated infection rates and infection-detection rates over time by age group (A–E) and overall (F)
Black box plots show the estimated median, 50% CrI, and 95% CrI of infection rate, and the red lines show the estimated median infection-detection rate and the red shaded area shows the 50% CrI 
(dark red) and the 95% CrI (light red) of estimated infection detection rate. Horizontal arrows indicate the timing of two major public health intervention measures—ie, school closures starting the 
week of March 15, 2020, and the stay-at-home order starting the week of March 22, 2020. CrI=credible interval.
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to be due to SARS-CoV-2 infection, the overall infection-
fatality risk would be around 1·10% (ie, 1·39% × 0·789). 
Examining estimates by age group, the estimated 
infection-fatality risk was lowest in young age groups, 
increasing substantially with age (table; figure 4). These 
estimates were similar to infection-fatality risks reported 
for China for corres ponding age groups.3 However, the 
estimated infection-fatality risk for the two oldest age 
groups was much higher than the younger age groups 
and about twice as high as the rates reported for these age 
groups in China.3,4 Additionally, the estimated infection-
fatality risk fluctu ated substantially over time for the two 
oldest age groups. For those aged 65–74 years, the 
estimated infection-fatality risk was 6·72% (95% CrI 
5·52–8·01) during the week of April 5, 2020, but decreased 
to 4·20% (2·22–7·01) during the week of May 31, 2020 
(figure 4). For those aged 75 years and older, estimated 
infection-fatality risk was 19·11% (14·70–21·92) during 
the week of April 5, 2020, but decreased to 10·38% 
(6·17–14·96) during the week of May 31, 2020 (figure 4).
Discussion
In light of the large uncertainties in infection-fatality risks 
for SARS-CoV-2 due to under-detection of infec tions, we 
used a model-inference system, developed to support the 
pandemic response in New York City, to estimate local 
infection-fatality risks. During the 2020 spring pandemic 
(March 1–June 6, 2020), New York City recorded the 
largest number of COVID-19 cases and related deaths in 
the USA. Despite public health efforts to slow the 
pandemic (eg, via physical distancing), and to increase 
health-care capacity, 21 447 people died due to COVID-19 
in the city in the short span of 3 months. Based on this 
large number of deaths, the estimated overall infection-
fatality risk in New York City was 1·39% if both confirmed 
and probable COVID-19-related deaths were included or 
1·10% if only confirmed COVID-19-related deaths were 
included. Both estimates were higher than previously 
reported elsewhere (eg, about 0·7% in both China3 and 
France5). Importantly, New York City has nosologists who 
rapidly review all death certificates and record deaths into 
a unified electronic reporting system (the average death 
certification time was 22·2 h and 95% of deaths were 
certified within 3·1 days during the pandemic wave; 
unpublished data, New York City DOHMH, Huynh M). 
This mortality surveillance infrastructure and enhanced 
nosology thus allow more rapid and complete death 
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Figure 3: Estimated cumulative infection rates across neighbourhoods in New York City, NY, USA, by age group (A–E) and overall (F)
New York City has five boroughs (Manhattan, Bronx, Brooklyn, Queens, and Staten Island) and 42 neighbourhoods (shown by the black lines). The heat maps show the estimated median cumulative 
infection rates for the period March 1, to June 6, 2020, for each age group and neighbourhood. 
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As such, our estimates here probably reflect the 
underlying fatality risk of SARS-CoV-2 infection more 
accurately than do those in previous studies. Furthermore, 
because the public health infrastructure and health-care 
systems in New York City are probably stronger than in 
many other places,19 the higher infection-fatality risk 
estimated here suggests that the fatality risk from SARS-
CoV-2 might be higher in the USA and some other 
countries than has been previously reported. Notably, 
despite the large surge in cases and admissions to 
hospital, through quick expansion of health-care systems, 
most hospitals in New York City were able to meet 
demand for patient care during the pandemic. Because 
COVID-19 continues to pose pandemic risk in many 
places worldwide, governments must account for and 
closely monitor the infection rate and health out comes, 
including admissions to hospital and mortality, and take 
prompt public health responses accordingly.
Although the infection-fatality risk we estimated here 
was similar to that previously reported elsewhere for 
younger age groups,3,5 we found that the infection-fatality 
risk for individuals aged 65 years and older in New York 
City were about twice as high as in reports from other 
locations.3 These higher infection-fatality risk estimates 
might be in part due to differences in population 
characteristics, in particular, the prevalence of underlying 
medical conditions such as diabetes, chronic lung 
disease, and cardiovascular disease.20,21 Regardless, our 
estimated weekly infection-fatality risk was as high as 
6·7% for those aged 65–74 years and 19·1% for those 
aged 75 years and older. These dire estimates highlight 
the increased risk of COVID-19-related mortality in older 
populations and the importance of infection prevention 
in congregate settings. Thus, early detection and 
adherence to infection control guidance in long-term and 
adult care facilities should be a priority for COVID-19 
response as the pandemic continues to unfold.
Over 5000 COVID-19-related deaths occurred among 
adults aged 25–64 years during the study period. Despite 
this large number of deaths, estimated cumulative 
infection rates in these age groups were only around 20% 
by the week of May 31, 2020, much lower than the 50–70% 
herd immunity needed to prevent large epidemics of 
COVID-19 (assuming the basic reproductive number for 
SARS-CoV-2 is around 2·0–3·5 and infection confers long-
lasting immunity).5,22,23 By July, 2020, many places where 
lockdown-like measures were lifted saw increases in the 
number of cases of COVID-19 among young adults.24–26 
These continuous infections could ignite new epidemics 
of COVID-19 and lead to further devastating effects in 
older populations and in younger adults (in particular, 
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Figure 4: Estimated infection-fatality risk, by age group (A–E) and overall (F)
Red lines show the estimated median infection-fatality risk with shaded areas indicating the 50% CrI (dark red) and 95% CrI (light red). For comparison, the grey bars show the number of deaths 
reported for each week from the week of March 1, to the week of May 31, 2020.
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population susceptibility in many places and trans mission 
across age groups. As such, young adults must strictly 
adhere to physical distancing and preventive measures 
(eg, mask wearing) in places with continuous transmission, 
despite their relatively low infection-fatality risk.
In this study, we incorporated multiple data sources, 
including age-grouped, spatially resolved case and morta-
lity data and mobility data, to calibrate our model-
inference system. Notably, the timing of the peak of the 
COVID-19 pandemic varied substantially among New 
York City neighbour hoods. For instance, peak mortality 
rates occurred up to 8 weeks apart among the 
42 neighbourhoods. Fitting the model-inference system 
simultaneously to these diverse case and mortality time 
series thus enabled improved constraint of key model 
parameters (eg, infection detection rate and infection-
fatality risk). 
We note there remain large uncertainties in our model 
estimates. A full assessment of COVID-19 severity 
will require comprehensive serological surveys of the 
population by age group and neighbourhood due to the 
large hetero geneity of infection rates across populations 
and space. Additionally, we only included deaths that 
were laboratory confirmed as related to SARS-CoV-2 
infection or explicitly coded as related to COVID-19. 
Previous studies have reported that excess deaths in New 
York City during about the same period were over 
24 000,10,27 which are more than the 21 447 COVID-19-
related deaths included in this study. Furthermore, 
studies have reported severe sequelae of COVID-19 
in children—ie, multisystem inflammatory syndrome 
in children.28,29 Thus, monitoring health outcomes in 
younger age groups after infection is important as the 
pandemic unfolds, despite the low infection-fatality risk 
in these age groups noted to date.
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